The surgical microscopes market is anticipated to reach $915.6 million by 2021, according to a MarketsandMarkets report.
Here are five highlights:
1. The market will grow at a compound annual growth rate of 12.5 percent between 2016 and 2021.
2. Basel, Switzerland-based Novartis, Washington, D.C.-based Danaher Corp., Tokyo, Japan-based Topcon Corp., Oberkochen, Germany-based Carl Zeiss and Wedel, Germany-based Haag-Streit Surgical lead the market.
3. Market drivers include the growing use of fluorescence image-guided surgery; rising number of minimally invasive surgeries; improving healthcare infrastructure; and increasing number of customized microscopy solutions.
4. The costliness of advanced surgical microscopes; the U.S. government excise tax; and high custom duties on medical devices will serve as obstacles to growth.
5. In 2016, the neuro/spine segment captured the largest market share, but the oncology segment will likely see the highest CAGR through 2021.